AzTrials
AzTrials

White Blood Cells Engulfing Red Blood CellsNCT03943277

Usefulness of White Blood Cell Count (WBCC) During Infection in Geriatric Patient

An observational study of White Blood Cells Engulfing Red Blood Cells, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In the general population, increased WBCC and neutrophil count are widely used as markers for infection during inflammatory states 1. However, 32% of geriatric patients with an infection do not develop an increase in WBCC 2. Read more about this study

Who is it for?
Ages 18 years and older
How many people
62 participants
Where
1 siteBelgium
Study dates
20 May 2019to 30 Jun 2024
How long will I take part?
2 Weeks
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Young and older patient with an inflammatory syndrome (CRP > 10 mg/dl) with or without infection

Who may be able to join

  • Acute inflammation is defined as a CRP ≥ 10 mg/l. We will include 2 groups of participants:
  • A) A group with an inflammatory syndrome and infection; infection being defined as:
  • Viral infection confirmed by nasopharynx swab for: influenza, RSV, parainfluenza, rhinovirusses, coronavirusses.
  • Bacterial infection confirmed with positive blood culture, positive articular punction, positive expectorations, pneumonia on chest radiograph, or infection documented by abdominal imagery (CT or echo), a positive urine culture with a confirmed pyelonephritis with a renal echography or a DMSA scintigraphy or specific clinical symptoms for pyelonephritis and positive hemoculture. A positive urine culture alone is not considered as urine infection because of the high prevalence of asymptomatic bacteriuria in geriatric patients.
  • B) A group with inflammatory syndrome and inflammatory diseases without infection: defined as:
  • Confirmed pulmonary embolism (PE) by CT or ventilation-perfusion scintigraphy
  • Microcrystalline arthritis diagnosed by articular punction
  • Crush syndrome or rhabdomyolyses defined by history of a fall and raised creatine kinase in blood sample.

Who cannot join

  • Immunosuppressive therapy (NSAIDs, corticosteroids, chemotherapy, immunotherapy), active cancer, antibiotics before admission, hematological diseases

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • UZ Brussel

    Brussels, 1090

Other trials in Belgium

About this study

Official title: Usefulness of White Blood Cell Count (WBCC) During Infection: a Comparison Between Hospitalized Geriatric and Young Groups.

In the general population, increased WBCC and neutrophil count are widely used as markers for infection during inflammatory states 1. However, 32% of geriatric patients with an infection do not develop an increase in WBCC 2. The hypothesis is that with inflammation, geriatric patients have a misadapted response of the immune system (IS) 3.

Our recent retrospective study 4 has shown that total and differential WBCC were not correlated with infection in a geriatric hospitalized population. Therefore, WBCC does not seem to be a reliable marker for infection in geriatric hospitalized patients. The neutrophil/lymphocyte ratio, and CRP, seem to be better markers.

Read more

the aim of the study to investigate this hypothesis prospectively and assess the role of aging and chronic diseases (such as cardiovascular diseases (CVD) and risk factors (CVRF) 5, cytomegalovirus (CMV) infection 6, periodontitis 7, onychomycosis 8 ) in this process and assess the role of a geriatric assessment.

To assess the usefulness of WBCC in the diagnosis of infection in geriatric patients and to address the contribution of ongoing chronic co-morbidities and age to WBCC-kinetics during an acute inflammatory syndrome, young and geriatric hospitalized patients with an inflammatory syndrome with and without infection will be compared

Read the detailed description

Study design Observational prospective study

The subjects Number of subjects 200 subjects: Average value CRP: group 1: 55; group 2: 84 Average standard deviation: 70.52 Power 80%: 158 deelnemers Power 90%: 202 deelnemers alpha = 0.05 2-sample T-test.

Inclusion criteria

Acute inflammation is defined as a CRP ≥ 10 mg/l. We will include 2 groups of participants:

  • A) A group with an inflammatory syndrome and infection; infection being defined as:
  1. Viral infection confirmed by nasopharynx swab for: influenza, RSV, parainfluenza, rhinovirusses, coronavirusses.
  2. Bacterial infection confirmed with positive blood culture, positive articular punction, positive expectorations, pneumonia on chest radiograph, or infection documented by abdominal imagery (CT or echo), a positive urine culture with a confirmed pyelonephritis with a renal echography or a DMSA scintigraphy or specific clinical symptoms for pyelonephritis and positive hemoculture. A positive urine culture alone is not considered as urine infection because of the high prevalence of asymptomatic bacteriuria in geriatric patients.
  • B) A group with inflammatory syndrome and inflammatory diseases without infection: defined as:
  1. Confirmed pulmonary embolism (PE) by CT or ventilation-perfusion scintigraphy
  2. Microcrystalline arthritis diagnosed by articular punction
  3. Crush syndrome or rhabdomyolyses defined by history of a fall and raised creatine kinase in blood sample.

Exclusion criteria Immunosuppressive therapy (NSAIDs, corticosteroids, chemotherapy, immunotherapy), active cancer, antibiotics before admission, hematological diseases

Replacement of subjects None.

Restrictions and prohibitions for the subjects None.

Procedures

  1. Questionnaires: taken at UZ Brussels
  • Social: age, home, sex, marital status.
  • Clinical: smoking and alcohol habits, streptococcus pneumoniae and influenza vaccination status, allergies, BMI, medical history, current treatment, reason for current hospitalization.
  • Comprehensive geriatric assessment:
  • CIRS-G (Cumulative Illness Rating Score): to quantify disease burden. It rates each organ system on a scale of 0 to 4, and differentiates older adults with the highest risk of and severity of infection, from those with lower infection risk. 20
  • Katz scale (ADL: assessment of activities of daily living): It rates 6 tasks of daily living (bathing, dressing, toilet, transfer, continence and eating) on a scale from 1 to 4. A low score means absence of dependence, and a high score the maximum of dependence for the task. 21
  • MMSE (Mini Mental Status Examination): a 0-30 score of cognitive functions, <24/30 meaning cognitive function impairment. 22 Patients with dementia:the investigators will request approval to be included in the study to the family of the patients.
  • MUST (Malnutrition Universal Screening Tool): to assess nutritional status. It divides patients into 3 groups: A low risk of malnutrition (score 0). A medium risk of malnutrition (score 1): then it is recommended to observe the patient for dietary intake. A high risk of malnutrition (score ≥2): treat the malnutrition. 23
  • Questionnaire for periodontal health. The newly developed questionnaire produces a reliable assessment of the individual risk of periodontitis (total score) and the need for periodontal treatment as well as the differentiation between gingivits and peridontitis. 24
  • Grip strength: Inflammatory states in the elderly are also associated with a decrease in muscle strength and fatigue resistance, as seen at UZ Brussels by Bautmans et al. The reduced strength and fatigue resistance in geriatric patients with inflammation are significantly related with the concentration of circulating CRP levels. 25 In the study, the investigators will use the martin vigorimeter which is at our disposal at the geriatrics ward of UZ Brussels, to measure the patients' grip strength and muscle fatiguability and determine which factors seem to contribute to a decrease in muscle strength (CRP, CVD, CVR, infection, periodontitis, CMV status, onychomycosis, age). the investigators will use the Martin vigorimeter (Elmed, Addison, IL) to assess grip strength and fatiguibility. The investigators will ask the patients to squeeze the rubber bulb of the vigorimeter as hard as possible in 3 consecutive attempts, to assess their grip strength. The highest score for each hand is recorded. Fatigue resistance will be assessed by asking the patient to squeeze the bulb of the vigorimeter as hard as possible and to maintain this pressure as long as possible; the time (seconds) until the pressure diminished to half of the maximal grip strength is recorded for each hand.25 26 B) Collection of data from physical examination C) Clinical evaluation of onychomycosis of the toenails: the investigators will perform a clinical examination of the toenails. Following parameters are found to be significantly related to positive mycology results in onychomycosis patients 8: scaling on one or both soles, white crumbly patches on the nail surface, and an abnormal colour of the nail.
  1. Follow up of bacterial and viral culture analyses

Observational data from bacterial and viral samples during hospitatalization :

  1. Viral infection confirmed by nasopharynx swab for: influenza, RSV, parainfluenza, rhinovirusses, coronaviruses
  2. Bacterial infection confirmed with positive blood culture, positive articular punction, positive expectorations, pneumonia on chest radiograph, or infection documented by abdominal imagery (CT or echo), a positive urine culture with a confirmed pyelonephritis with a renal echography or a DMSA scintigraphy or specific clinical symptoms for pyelonephritis and positive hemoculture. A positive urine culture alone is not considered as urine infection because of the high prevalence of asymptomatic bacteriuria in geriatric patients.
  3. Follow up of blood analyses:

Observational data from blood samples during hospitalization:

  • Day 0 (at the emergency department): CRP, total and differential WBCC, renal function
  • Day 1: at hospitalization, within 24h of admission
  • Geriatric patients: CRP, total and differential WBCC, renal function, hepatic function (transaminases), albumin, prealbumin, protein profile and monoclonal protein, vitamin B12, folic acid, hemoglobin, hematocrit, TSH, CMV-serology.
  • Young patients: CRP, total and differential WBCC, renal function, albumin, vitamin B12, folic acid, TSH, CMV-serology.
  • Day 3: CRP, total and differential WBCC.
  • Day 5: CRP, total and differential WBCC.

Flowchart Questionnaires, blood samples: conducted by Hanne Maes. Supervising MD: Dr. Nathalie Compté, UZ Brussels.

Randomisation/blinding Observational study, not applicable.

Prior and concomitant therapy All medication can be continued during this study.

Study analysis Statistical analysis the investigators will perform student t-tests or Mann-Whitney rank sum tests to compare geriatric/young patients with and without infection. To assess the contribution of age, comorbidities and geriatric syndrome in the kinetics of WBCC, the investigators will perform univariate and multivariate analyses.

Being tested
No intervention, observational study

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No intervention, observational studyOther

    No intervention observational study

Study groups in NCT03943277
Study groupRoleWhat they receive
patient with infectionAcute inflammation is defined as a CRP ≥ 10 mg/l. We will include 2 groups of participants: A group with an inflammatory syndrome and infection; infection being defined as: 1. Viral infection confirmed by nasopharynx swab for: influenza, RSV, parainfluenza, rhinovirusses, coronavirusses. 2. Bacterial infection confirmed with positive blood culture, positive articular punction, positive expectorations, pneumonia on chest radiograph, or infection documented by abdominal imagery (CT or echo), a positive urine culture with a confirmed pyelonephritis with a renal echography or a DMSA scintigraphy or specific clinical symptoms for pyelonephritis and positive hemoculture. A positive urine culture alone is not considered as urine infection because of the high prevalence of asymptomatic bacteriuria in geriatric patients.
Receives: Other: No intervention, observational study
patient without infectionAcute inflammation is defined as a CRP ≥ 10 mg/l. We will include 2 groups of participants: => B) A group with inflammatory syndrome and inflammatory diseases without infection: defined as: 1. Confirmed pulmonary embolism (PE) by CT or ventilation-perfusion scintigraphy 2. Microcrystalline arthritis diagnosed by articular punction 3. Crush syndrome or rhabdomyolyses defined by history of a fall and raised creatine kinase in blood sample.
Receives: Other: No intervention, observational study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Usefulness of white blood cell count (WBCC) during infection in geriatric patient

    observation of WBCC is correlated with infection by older patient

    Measured: 1.5 years

  2. Delta of wbcc

    the significance of a Delta of WBCC (Delta= □((White blood cell count during acute infection or acute inflammatory events)/(White blood cell count in chronic circumstances)) ) in geriatric patients with acute infections or inflammatory events

    Measured: 1.5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 May 2019
  2. Study start20 May 2019
  3. Primary completion30 Jun 2024
  4. Study completion30 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
62 participants (actual)
Target duration
2 Weeks
IDs, dates and publications
ClinicalTrials.gov ID
NCT03943277
Sponsor's protocol ID
UZCompte1
Status last verified
Dec 2024
First submitted
25 Apr 2019
Last updated
5 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: data will be maybe described in an article

Publications

  • Compte N, Dumont L, Bron D, De Breucker S, Praet JP, Bautmans I, Pepersack T. White blood cell counts in a geriatric hospitalized population: A poor diagnostic marker of infection. Exp Gerontol. 2018 Dec;114:87-92. doi: 10.1016/j.exger.2018.11.002. Epub 2018 Nov 6.

    PubMed 30412726
  • Compte N, Bailly B, De Breucker S, Goriely S, Pepersack T. Study of the association of total and differential white blood cell counts with geriatric conditions, cardio-vascular diseases, seric IL-6 levels and telomere length. Exp Gerontol. 2015 Jan;61:105-12. doi: 10.1016/j.exger.2014.11.016. Epub 2014 Nov 22.

    PubMed 25446500

Questions about this trial

What is this clinical trial studying?

An observational study of White Blood Cells Engulfing Red Blood Cells, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Usefulness of white blood cell count (WBCC) during infection in geriatric patient (time frame: 1.5 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03943277, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2024; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in